Andrews Simon, Stephens Len R, Hawkins Phillip T
Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Sci STKE. 2007 Oct 9;2007(407):cm2. doi: 10.1126/stke.4072007cm2.
Class I phosphoinositide 3-kinases (PI3Ks) are well-established signal transduction enzymes that play an important role in the mechanisms by which a wide variety of cell surface receptors control several cellular functions, including cellular growth, division, survival, and movement. Class IB PI3K (also known as PI3Kgamma) allows fast-acting, heterotrimeric GTP-binding protein-coupled receptors to access this pathway. Activation of class IB PI3K results in the rapid synthesis of phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] and its dephosphorylation product, PI(3,4)P2, in the plasma membrane. These two lipid messengers bind to multiple, pleckstrin homology (PH) domain-containing effectors, which together regulate a complex signaling web downstream of receptor activation. This pathway regulates the activity of protein kinases and small guanosine triphosphatases that control cellular movement, adhesion, contraction, and secretion. Most of the ligands that have been established to activate class IB PI3K are involved in coordinating the body's response to injury and infection through the regulation of multiple cell types in the immune system and vascular lining. Mice lacking the catalytic subunit of class IB PI3K are remarkably resistant to the development of several inflammatory pathologies in mouse models of human inflammatory disease. These results suggest small molecule inhibitors of class IB PI3K may represent a novel class of therapeutic agents that may complement existing anti-inflammatory treatments.
I类磷酸肌醇3激酶(PI3Ks)是公认的信号转导酶,在多种细胞表面受体控制多种细胞功能(包括细胞生长、分裂、存活和运动)的机制中发挥重要作用。I B类PI3K(也称为PI3Kγ)使快速作用的异源三聚体GTP结合蛋白偶联受体能够进入该信号通路。I B类PI3K的激活导致质膜中磷脂酰肌醇-3,4,5-三磷酸[PI(3,4,5)P3]及其去磷酸化产物PI(3,4)P2的快速合成。这两种脂质信使与多种含普列克底物蛋白同源(PH)结构域的效应器结合,共同调节受体激活下游的复杂信号网络。该信号通路调节控制细胞运动、黏附、收缩和分泌的蛋白激酶和小GTP酶的活性。大多数已确定可激活I B类PI3K的配体通过调节免疫系统和血管内膜中的多种细胞类型,参与协调机体对损伤和感染的反应。在人类炎症性疾病小鼠模型中,缺乏I B类PI3K催化亚基的小鼠对几种炎症性病变的发展具有显著抗性。这些结果表明I B类PI3K的小分子抑制剂可能代表一类新型治疗药物,可补充现有的抗炎治疗。